Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

MedWellAI (MWAI) Shares Outstanding (Diluted Average) (2016 - 2025)

MedWellAI (MWAI) has disclosed Shares Outstanding (Diluted Average) for 10 consecutive years, with $6.3 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding (Diluted Average) rose 20.73% to $6.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6.3 million through Dec 2025, up 20.73% year-over-year, with the annual reading at $5.7 million for FY2025, 29.28% up from the prior year.
  • Shares Outstanding (Diluted Average) for Q4 2025 was $6.3 million at MedWellAI, up from $6.2 million in the prior quarter.
  • The five-year high for Shares Outstanding (Diluted Average) was $291.2 million in Q4 2021, with the low at $1.6 million in Q1 2022.
  • Average Shares Outstanding (Diluted Average) over 5 years is $57.1 million, with a median of $5.3 million recorded in 2024.
  • The sharpest move saw Shares Outstanding (Diluted Average) plummeted 99.31% in 2022, then soared 681.51% in 2024.
  • Over 5 years, Shares Outstanding (Diluted Average) stood at $291.2 million in 2021, then tumbled by 99.31% to $2.0 million in 2022, then soared by 111.37% to $4.2 million in 2023, then rose by 22.98% to $5.2 million in 2024, then grew by 20.73% to $6.3 million in 2025.
  • According to Business Quant data, Shares Outstanding (Diluted Average) over the past three periods came in at $6.3 million, $6.2 million, and $5.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.